Tonix Pharmaceuticals Holding (TNXP) Net Shares Issued and Repurchased (2017 - 2026)

Tonix Pharmaceuticals Holding has reported Net Shares Issued and Repurchased for 10 years, with the latest figure at $1.0 million in Q1 2026.

• On a quarterly basis, Net Shares Issued and Repurchased rose 53.3% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $1.0 million, a 53.3% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 34931.52% from the prior year.
• Net Shares Issued and Repurchased was $1.0 million for Q1 2026 at Tonix Pharmaceuticals Holding, down from $1.2 million in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $40.7 million in Q1 2022, with the low at $374.0 in Q4 2023.
• Average Net Shares Issued and Repurchased over 5 years is $6.5 million, with a median of $1.0 million recorded in 2026.
• The sharpest annual moves came in 2023 and 2025: Net Shares Issued and Repurchased slumped 99.87% in 2023, then soared 34931.52% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $298657.0 in 2022, then plunged by 99.87% to $374.0 in 2023, then jumped by 825.4% to $3461.0 in 2024, then jumped by 34931.52% to $1.2 million in 2025, then retreated by 15.25% to $1.0 million in 2026.
• The last three Net Shares Issued and Repurchased figures came in at $1.0 million (Q1 2026), $1.2 million (Q4 2025), and $670291.0 (Q1 2025), per Business Quant data.